Rilotumumab Antibody
Rilotumumab (AMG 102) is a fully human monoclonal antibody that neutralizes hepatocyte growth factor (HGF) to block HGF/MET signaling pathways. It has demonstrated antitumor activity in preclinical studies, making it a relevant tool for investigating MET-driven cancers such as castration-resistant prostate cancer and gastric cancer in both in vitro and in vivo research models.
Product Specifications
Product Name Alternative
AMG 102, AMG102, AMG-102, cMet/HGFR, c-Met/HGFR, c-Met, cMet, HGFR, Rilotumumab
Target
C-Met/HGFR
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Signal Transduction
Concentration
14.86 mg/mL
Purity
97.51% (May vary between batches)
Molecular Weight
145.2 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Metabotropic Glutamate Receptor 3 (GRM3) Rabbit Polyclonal Antibody
